Two scientists with extensive industrial drug discovery and development experience recently joined
Menu
The Institute primarily focuses on understanding the pathobiology of hepatitis B virus and related diseases, developing diagnostics for early detection of liver cancer, and discovering therapeutics, antivirals and immune modulators for the cure of chronic HBV and other RNA viruses that cause hepatitis and hemorrhagic fever.
For the treatment of chronic HBV and flavivirus infections such as yellow fever.
The Blumberg Institute Seminar Series, a free and public initiative to promote global scientific exchange, features renowned field leaders such as the 2023 Nobel Prize Laureate Drew Weissman.
The Blumberg Institute Seminar Series, a free and public initiative to promote global scientific exchange, features renowned field leaders such as the 2023 Nobel Prize Laureate Drew Weissman
Our esteemed scientific faculty's expertise spans diverse disciplines, driving innovation and advancing knowledge for a better tomorrow.
The Blumberg Institute is at the forefront of groundbreaking research to understand the hepatitis B virus, develop better treatments, and ultimately find a cure. This life-saving work depends on generous support from donors like you. Your contribution can advance our research and potentially save millions of lives.
The Blumberg Institute, Hepatitis B Foundation and Pennsylvania Biotechnology Center offers transformative education programs for high school students and undergraduate research fellows. Your gift can put lab coats on students, ignite their passion for science, and launch their careers in the life sciences!
Two scientists with extensive industrial drug discovery and development experience recently joined
Governor Kathy Hochul New York State officials today announced
Dr. Timothy Block will share his thoughts about launching the Foundation, Blumberg
June 5, 2024 Following is noteworthy news about people who work at
Joel D. Rosen, Esq, managing partner of High Swartz LLP, has been
Dr. Kunwar Shailubhai Biotech entrepreneur and Blumberg Institute professor Kunwar Shailubhai, PhD,
The authors are Blumberg Institute scientists and colleagues at the University of
Through a pilot program aimed at accelerating and supporting life sciences startups in our state, the Pennsylvania Biotechnology Center
(L-R) Zhengyuan Jiang of the Blumberg Institute, Dr. Patrick Y. S. Lam
June 6, 2023 Taimoor Khan, PhD, has joined the Blumberg Institute as